Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. is a biotechnology firm dedicated to advancing therapeutic treatments through its expertise in genome editing. The company's pipeline includes several in vivo (administered within the body) programs. NTLA-2001 is currently undergoing a Phase 1 clinical trial for transthyretin amyloidosis, while NTLA-2002 targets hereditary angioedema. Additionally, Intellia is developing various other liver-focused therapies for conditions such as hemophilia A and B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo (processed outside the body) pipeline features NTLA-5001, a candidate for acute myeloid leukemia. The company is also progressing proprietary programs focused on creating engineered cell therapies to address diverse oncological and autoimmune disorders. At the core of Intellia's technology is the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has established multiple licensing and collaboration agreements. These include a partnership with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for treating sickle cell disease, and a co-development agreement with Regeneron Pharmaceuticals, Inc. for potential products against hemophilia A and B. The company also collaborates with Ospedale San Raffaele and holds a strategic alliance with SparingVision SAS to develop novel genomic medicines for ocular diseases, leveraging CRISPR/Cas9 technology. The company, initially known as AZRN, Inc., was founded in 2014 and operates from its headquarters in Cambridge, Massachusetts.
Sector: In Vitro & In Vivo Diagnostic Substances
Industry: Biotechnology
Intellia Therapeutics, Inc.
NASDAQ:NTLAHealthcare · Biotechnology
-5.74%$12.47
AH$12.35-0.96%vs close
Mkt Cap$1.75B
Float115.06M
O/S140.13M
Vol
$ Vol
RVOL
Inst Own-
SI38.6%
Earnings
Dilution
Financials Summary
Revenue$67.67M
Net Income-$412.69M
Total Assets$842.13M
Free Cash Flow-$354.66M
Debt & Equity
Debt 12%
Equity 88%
Total Debt$93.33M
Total Equity$671.39M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in NTLA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$842.13M
Liabilities$170.73M
Accounts Receivable$9.47M
Accounts Payable$20.25M
Inventory$0
PP&E (Net)$123.63M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $67.67M | $57.88M | $36.27M | $52.12M | $33.05M | $57.99M | $43.1M | $30.43M | $26.12M | $16.48M | $6.04M | $0 |
| YoY Growth | 16.9% | 59.6% | -30.4% | 57.7% | -43.0% | 34.5% | 41.6% | 16.5% | 58.5% | 172.7% | - | - |
| Cost of Revenue | $15.92M | $10.29M | $8.98M | $7.57M | $6.89M | $150.41M | $108.41M | $89.11M | $67.65M | $31.84M | $11.17M | $1.66M |
| Gross Profit | $51.75M | $47.59M | $27.3M | $44.55M | $26.16M | -$92.41M | -$65.31M | -$58.68M | -$41.53M | -$15.36M | -$5.13M | -$1.66M |
| Gross Margin | 76.5% | 82.2% | 75.3% | 85.5% | 79.2% | -159.4% | -151.5% | -192.8% | -159.0% | -93.2% | -84.8% | - |
| Research and Development | $388.86M | $466.31M | $435.07M | $419.98M | $229.81M | $150.41M | $108.41M | $89.11M | $67.65M | $31.84M | $11.17M | $10.74M |
| Selling, General, and Administrative | $119.8M | $125.83M | $116.5M | $90.31M | $71.1M | $44.17M | $41.06M | $32.19M | $28.02M | $16.8M | $8.28M | $3.57M |
| Other | -$15.92M | -$10.29M | -$8.98M | -$7.57M | -$6.89M | -$150.41M | -$108.41M | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $492.74M | $581.86M | $542.59M | $502.71M | $294.01M | $44.17M | $41.06M | $121.3M | $95.67M | $48.64M | $19.45M | $12.65M |
| Operating Income (EBIT) | -$440.99M | -$534.26M | -$515.29M | -$458.16M | -$267.85M | -$136.58M | -$106.37M | -$90.87M | -$69.56M | -$32.16M | -$13.41M | -$5.23M |
| Operating Margin | -651.7% | -923.1% | -1420.5% | -879.0% | -810.4% | -235.5% | -246.8% | -298.6% | -266.3% | -195.2% | -221.9% | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $29.2M | $47.81M | $49.83M | $8.54M | $1.28M | $2.35M | $6.83M | $5.53M | $2.01M | $525K | $0 | $0 |
| Other Income (Expense) | $28.3M | $15.24M | $34.1M | -$16.02M | -$42K | $2.35M | $6.83M | $5.53M | $2.01M | $525K | $0 | -$9.08M |
| Income Before Tax (EBT) | -$412.69M | -$519.02M | -$481.19M | -$474.19M | -$267.89M | -$134.23M | -$99.53M | -$85.34M | -$67.54M | -$31.63M | -$13.41M | -$14.31M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.01M | $0 |
| Net Income | -$412.69M | -$519.02M | -$481.19M | -$474.19M | -$267.89M | -$134.23M | -$99.53M | -$85.34M | -$67.54M | -$31.63M | -$12.4M | -$14.31M |
| Net Income Margin | -609.9% | -896.8% | -1326.5% | -909.8% | -810.5% | -231.5% | -230.9% | -280.4% | -258.6% | -192.0% | -205.1% | - |
| Supplementary Data | ||||||||||||
| EPS | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 | -1.96 | -1.98 | -1.88 | -0.91 | -0.70 | -1.39 |
| Diluted EPS | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 | -1.96 | -1.98 | -1.88 | -0.91 | -0.70 | -1.39 |
| Weighted Average OS | 108.38M | 98.85M | 88.77M | 76.97M | 70.89M | 55.99M | 47.25M | 43.07M | 36.01M | 34.62M | 17.66M | 10.29M |
| EBITDA | -$396.77M | -$508.74M | -$472.22M | -$466.61M | -$261M | -$130.27M | -$100.78M | -$86.41M | -$66.56M | -$31.05M | -$13.08M | -$9.54M |
| EBITDA Margin | -586.3% | -879.0% | -1301.8% | -895.3% | -789.6% | -224.6% | -233.8% | -283.9% | -254.9% | -188.5% | -216.4% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $155.46M | $189.18M | $226.75M | $523.51M | $123.41M | $160.02M | $57.23M | $58.86M | $340.68M | $273.06M | $75.82M | $9.85M |
| Short-Term Investments | $294.42M | $412.33M | $685.48M | $669.12M | $625.28M | $437.35M | $222.5M | $255.2M | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $449.88M | $601.51M | $912.22M | $1.19B | $748.69M | $597.37M | $279.73M | $314.06M | $340.68M | $273.06M | $75.82M | $9.85M |
| Accounts Receivable | $9.47M | $8.52M | $36.46M | $3.77M | $2.03M | $2.13M | $4.62M | $7.55M | $10.47M | $6.45M | $1M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $68.36M | $29.83M | $49.65M | $20.41M | $0 | $0 | $0 | $3.37M | $3.68M | $1.79M | $0 | $0 |
| Total Current Assets | $527.71M | $639.86M | $998.33M | $1.22B | $769.3M | $616.52M | $289.48M | $324.98M | $354.83M | $281.31M | $77.63M | $10.13M |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $123.63M | $246.67M | $148.13M | $161M | $100.11M | $55.06M | $37.13M | $17.06M | $15.27M | $10.63M | $2.71M | $308K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $35.54M | $44.26M | $154.51M | $142.32M | $425.05M | $4.75M | $4.75M | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $155.25M | $260.21M | $0 | $0 | $0 | $0 | $2.92M | $5.28M | $6.13M | $7.04M | $1.8M | $256K |
| Total Long-Term Assets | $314.42M | $551.15M | $302.65M | $303.32M | $525.16M | $59.8M | $44.8M | $22.34M | $21.41M | $17.66M | $4.51M | $564K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $842.13M | $1.19B | $1.3B | $1.52B | $1.29B | $676.32M | $334.28M | $347.31M | $376.24M | $298.97M | $82.14M | $10.69M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $20.25M | $14.59M | $7.45M | $5.15M | $9.65M | $10.46M | $3.94M | $2.71M | $2.17M | $4.65M | $1.36M | $199K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $7.29M | $20.66M | $22.14M | $43.84M | $63.76M | $22.54M | $12.67M | $27.12M | $21.19M | $20.18M | $6.55M | $0 |
| Other Current Liabilities | $23.07M | $24.07M | $6.89M | $21.78M | $20.36M | $10.92M | $6.31M | $4.57M | $3.23M | $3.2M | $1.51M | $0 |
| Total Current Liabilities | $103.88M | $110.85M | $115.21M | $126.55M | $125.83M | $64.25M | $35.63M | $40.57M | $31.36M | $30.73M | $10.7M | $2.35M |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $66.85M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $18.26M | $38.85M | $19.93M | $63.48M | $51.39M | $16.14M | $28.81M | $44.11M | $58.11M | $3.77M | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | -$38.85M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $38.85M | $24.03M | $0 | $0 | $0 | $13K | $168K | $293K | $323K | $773K |
| Total Long-Term Liabilities | $66.85M | $208.21M | $135.6M | $157.98M | $128.39M | $85M | $28.77M | $28.82M | $44.28M | $58.4M | $4.09M | $773K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $170.73M | $319.06M | $250.81M | $284.53M | $254.22M | $149.25M | $64.4M | $69.39M | $75.64M | $89.13M | $14.78M | $3.13M |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $88.56M | $16.45M |
| Common Stock | $12K | $10K | $9K | $9K | $7K | $7K | $5K | $5K | $4K | $4K | $3K | $657K |
| Retained Earnings | -$2.59B | -$2.18B | -$1.66B | -$1.18B | -$703M | -$435.11M | -$300.88M | -$201.03M | -$121.11M | -$53.57M | -$21.94M | -$9.54M |
| Comprehensive Income & Other | $1.03M | $605K | -$2.26M | -$7.46M | -$2.63M | $1K | $261K | -$28K | $0 | $0 | -$88.56M | -$16.45M |
| Other Stockholders' Equity | $3.26B | $3.05B | $2.71B | $2.41B | $1.74B | $962.17M | $570.75M | $478.94M | $421.71M | $263.4M | $89.29M | $16.45M |
| Total Equity | $671.39M | $871.96M | $1.05B | $1.24B | $1.04B | $527.07M | $269.88M | $277.92M | $300.6M | $209.84M | $67.36M | $7.57M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $842.13M | $1.19B | $1.3B | $1.52B | $1.29B | $676.32M | $334.28M | $347.31M | $376.24M | $298.97M | $82.14M | $10.69M |
| Supplementary Data | ||||||||||||
| Total Debt | $93.33M | $210.2M | $115.35M | $130.7M | $74.02M | $39.3M | $18.38M | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$62.13M | $21.02M | -$111.4M | -$392.8M | -$49.38M | -$120.72M | -$38.85M | -$58.86M | -$340.68M | -$273.06M | -$75.82M | -$9.85M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$519.02M | -$519.02M | -$481.19M | -$474.19M | -$267.89M | -$134.23M | -$99.53M | -$85.34M | -$67.54M | -$31.63M | -$12.4M | -$14.31M |
| Depreciation & Amortization | $15.92M | $10.29M | $8.98M | $7.57M | $6.89M | $6.31M | $5.59M | $4.46M | $2.99M | $1.1M | $328K | $5K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $8.93M | $0 | $0 | $0 | $0 | -$6.7M | -$1.01M | $0 |
| Stock-Based Compensation | $154.27M | $154.27M | $134.05M | $91.4M | $47.01M | $19.9M | $15.09M | $17.05M | $15.32M | $6.71M | $1.31M | $462K |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | -$951K | $27.94M | -$32.69M | -$1.74M | $99K | $2.49M | $2.93M | $2.92M | -$4.02M | -$5.45M | -$1.01M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $7.82M | $0 | $1.65M | $3.96M | $1.28M | -$4.39M | $0 | $0 |
| Accounts Payable | $5.99M | $6.8M | $2.52M | -$4.58M | $529K | $5.06M | $1.88M | $232K | -$488K | $1.78M | $335K | $0 |
| Other Working Capital | -$78.79M | -$22.86M | -$22.29M | -$47.55M | -$31.36M | $49.98M | -$27.12M | -$3.94M | -$12.99M | $67.97M | $9.67M | $1.03M |
| Total Working Capital Change | -$73.75M | $11.88M | -$52.45M | -$53.87M | -$22.9M | $57.53M | -$20.66M | $3.18M | -$16.21M | $59.91M | $10M | $1.03M |
| Other Non-Cash Items | $73.7M | -$6.29M | -$3.47M | $95.8M | $2.94M | $573K | -$3.72M | -$601K | $166K | $6.71M | $9K | $9.33M |
| Net Cash from Operating | -$348.88M | -$348.88M | -$394.09M | -$333.29M | -$225.03M | -$49.91M | -$103.24M | -$61.26M | -$65.28M | $36.11M | -$1.76M | -$3.48M |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$5.78M | -$5.78M | -$13.98M | -$58.39M | -$12.76M | -$3.58M | -$6.79M | -$6.36M | -$10.09M | -$6.17M | -$2.55M | -$413K |
| Acquisitions | $0 | $0 | $0 | -$44.68M | -$3M | $0 | -$31.97M | $131K | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$935.57M | -$935.57M | -$904.46M | -$429.03M | -$1.02B | -$473.7M | -$297.03M | -$254.56M | $0 | $0 | $0 | $0 |
| Sales of Investments | $1.05B | $1.07B | $887.1M | $647.58M | $485.6M | $262.8M | $329M | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $20.97M | $0 | $0 | $44.83M | $0 | $0 | $31.97M | $131K | -$10K | $0 | $0 | -$450K |
| Net Cash from Investing | $125.57M | $125.57M | -$31.35M | $160.31M | -$550.78M | -$214.49M | $25.18M | -$260.78M | -$10.09M | -$6.17M | -$2.55M | -$863K |
| Financing Activities | ||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $131.49M | $176.9M | $119.8M | $565.79M | $693.57M | $358.65M | $72.26M | $28.55M | $141M | $170.51M | $74.06M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2.67M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $54.26M | $8.85M | $10.53M | $17.17M | $43.12M | $13.13M | $4.18M | $11.67M | $1.98M | -$3.1M | -$1.7M | $19.11M |
| Net Cash from Financing | $185.75M | $185.75M | $130.32M | $582.96M | $736.69M | $371.78M | $76.43M | $40.22M | $142.98M | $167.3M | $70.29M | $19.11M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$37.57M | -$37.57M | -$295.11M | $409.98M | -$39.12M | $107.38M | -$1.63M | -$281.82M | $67.61M | $197.25M | $65.97M | $14.77M |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$348.88M | -$348.88M | -$394.09M | -$333.29M | -$225.03M | -$49.91M | -$103.24M | -$61.26M | -$65.28M | $36.11M | -$1.76M | -$3.48M |
| Capital Expenditure | -$5.78M | -$5.78M | -$13.98M | -$58.39M | -$12.76M | -$3.58M | -$6.79M | -$6.36M | -$10.09M | -$6.17M | -$2.55M | -$413K |
| Free Cash Flow | -$354.66M | -$354.66M | -$408.07M | -$391.68M | -$237.79M | -$53.5M | -$110.03M | -$67.61M | -$75.37M | $29.94M | -$4.32M | -$3.9M |
| Cash at Beginning | $240.35M | $240.35M | $535.46M | $125.49M | $164.61M | $57.23M | $58.86M | $340.68M | $273.06M | $75.82M | $9.85M | $0 |
| Cash at End | $202.79M | $202.79M | $240.35M | $535.46M | $125.49M | $164.61M | $57.23M | $58.86M | $340.68M | $273.06M | $75.82M | $14.77M |